Pure Global
NCT05551819

Acceptability of a Microbiome-directed Food in Young Children With Acute Malnutrition

Acceptability of a Microbiome-directed Food for the Treatment of Children With Uncomplicated Acute Malnutrition in Niger
Epicentre·ClinicalTrials.gov·dietary supplementRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Malnutrition, Child
Drug/Device/Intervention
MDF then RUTF/RUSF
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Epicentre
Location
Guidan Roumji,Madarounfa, Niger
Timeline & enrollment
Phase
N/A
Start date
Oct 26, 2022
End date
Mar 15, 2023
Enrollment
292 participants
Primary outcome

Acceptability of test dose,Acceptability of at-home ration

Summary

This study will compare the acceptability a microbiome-directed food (MDF) with standard
 formulations of therapeutic/supplementary foods for the treatment of acute malnutrition using
 a 2 x 2 crossover design.

ICD-10 classifications
MalnutritionMalnutrition in pregnancySequelae of malnutrition and other nutritional deficienciesMalnutrition-related diabetes mellitusMalnutrition-related diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05551819
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05551819 through Pure Global AI's free database. This phase not specified trial is sponsored by Epicentre and is currently Recruiting. The study focuses on Malnutrition, Child. Target enrollment is 292 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.